US Material Events SEC 8-K Filings — July 17, 2026

Material Events Monitor

By Gunpowder Editorial ·

50 high priority 50 total filings analysed

Executive Summary

The July 17, 2026, filing cycle reveals a market dominated by significant capital markets activity, with a major IPO ($1.01B for Csquare), a large convertible note offering ($650M+ for Penguin Solutions), and a $1.14B ABS securitization by Uniti Group.

The most critical development is the receivership of Fuse Science, a terminal event for a micro-cap, while the sector sees a major strategic pivot in biotech with Jasper Therapeutics' dilutive acquisition of Kira Pharmaceuticals. A clear theme of financial distress and restructuring is evident, with companies like Trans American Aquaculture restating financials, Generation Income Properties fighting for Nasdaq compliance, and EyePoint Pharmaceuticals settling a False Claims Act case. On the positive side, there is a wave of strategic M&A, including IPG Photonics' acquisition of Lumibird Medical and several SPACs (Four Leaf, Mercator) pursuing new combinations. Leadership changes are widespread, but the most impactful are the CFO transitions at Energy Vault and Lindsay Corp, and the CEO transition at Adobe, which is triggering retention packages. Overall, the period is characterized by aggressive capital raising, strategic repositioning, and a clear bifurcation between companies with strong growth narratives and those facing existential challenges.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior US Material Events SEC 8-K Filings digest from July 16, 2026.

Investment Signals (12)

  • Acquiring Lumibird Medical for €300M (plus €50M earnout), a 21.5% EBITDA margin target, expected to be accretive to gross margin, EBITDA, and adjusted EPS. This is a strategic bolt-on that expands their medical laser platform at a reasonable valuation.

  • Completed a $1.01B IPO, with Brookfield as a major institutional investor holding significant board nomination rights. The massive capital raise and blue-chip backing signal strong institutional confidence in the company's growth strategy.

  • Appointed a new CFO from BlackRock's Direct Private Opportunities group, signaling a shift toward more sophisticated capital markets strategy. The company also reports accelerating growth with multi-GWh project wins and a material Q2 2026 backlog increase.

  • Appointed a new CCO from Mantech who grew a $4B+ pipeline and delivered double-digit YoY revenue growth. This signals a strong push to accelerate revenue in government and commercial markets.

  • Acquiring Kira Pharmaceuticals in a highly dilutive all-stock deal (existing shareholders diluted to ~6.7% ownership). While the combined pipeline is promising, the massive dilution and reliance on a $132M PIPE for funding through 2H 2028 is a significant risk.

  • Placed into receivership after failing to satisfy a $643K judgment, reporting $0 in assets and cash. The receiver has full authority to investigate insider transactions and wind down the business. This is a total loss for equity holders.

  • Restating FY2024 financials due to material errors in liability classification, accrued interest, and accounting for a deed in lieu of foreclosure. The company has material weaknesses in internal controls, including no functioning audit committee.

  • Settled False Claims Act violations for $4.8M and entered a 5-year Corporate Integrity Agreement. While the settlement avoids litigation, the ongoing compliance obligations and reputational damage are a significant overhang.

  • Amended preferred units to eliminate cash redemption rights to achieve permanent equity classification and meet Nasdaq's $2.5M equity requirement by August 4, 2026. This is a last-ditch effort to avoid delisting.

  • Board member Nancy Lipson resigned to pursue another opportunity, a departure that is not due to any disagreement. While routine, the loss of an experienced board member is a minor negative signal for a company in a competitive industry.

  • Refinanced $850M in Term Loans on a like-for-like basis with no new cash borrowed. This is a neutral event but demonstrates the company's ability to manage its debt maturity profile in a stable credit environment.

  • Increased the accordion feature on its credit facility from $800M to $1B, providing additional financial flexibility for future investments. This signals confidence in the lending environment and a desire to scale.

Risk Flags (10)

  • Company placed into receivership with $0 assets and $0 cash. The receiver is authorized to investigate insider transactions and cancel improperly issued shares. High risk of total equity wipeout.

  • Restating FY2024 financials due to multiple material errors. Material weaknesses in internal controls, including no functioning audit committee, indicate a systemic failure in financial reporting.

  • Amended preferred units to avoid delisting, but must demonstrate compliance by August 4, 2026. Failure to do so will result in delisting, a severe negative event.

  • Existing shareholders diluted to ~6.68% of the combined company post-acquisition. The $132M PIPE is critical to fund operations, and failure to achieve milestones (e.g., CVR payments) could lead to further dilution.

  • Settlement of False Claims Act and 5-year Corporate Integrity Agreement imposes significant compliance costs and oversight. Any future non-compliance could trigger severe penalties.

  • Proposal to decrease authorized shares was defeated, and director Jeff Kirby received significant abstentions and broker non-votes. This indicates a lack of shareholder confidence in management's capital allocation strategy.

  • Issued a convertible note with a 10% interest rate and a conversion price as low as $0.05, which is highly dilutive to existing shareholders. The 25% original issue discount further increases the cost of capital.

  • Amendment to note purchase agreement involves canceling and reissuing notes, with a new investor joining. The notes are secured by substantially all assets of a subsidiary, indicating a complex and potentially distressed capital structure.

  • Children's Place / Nasdaq Non-Compliance [MEDIUM RISK]

    Resignation of a board member reduced the audit committee to two members, violating Nasdaq's three-member requirement. The company has until May 2027 to cure, but this is a governance red flag.

  • Implemented a $3.7M retention program for key executives, including the CEO, to incentivize them to stay through a period of expected catalysts. The need for such a program suggests a high risk of departure.

Opportunities (10)

  • Acquiring Lumibird Medical for €300M, a company with €112.2M revenue and 21.5% EBITDA margin. The deal is expected to be accretive and expands IPG's platform in a high-growth medical market.

  • With $1.01B in net proceeds and a major institutional investor (Brookfield) on board, Csquare has significant firepower for M&A and growth. The IPO provides a clean balance sheet and a strong base for future expansion.

  • The appointment of a BlackRock veteran as CFO signals a potential shift toward more aggressive capital markets activity and improved financial discipline. The company's accelerating growth and multi-GWh project wins provide a strong operational backdrop.

  • The new CCO's track record of building a $4B+ pipeline and delivering double-digit revenue growth suggests Spire is poised for a significant revenue acceleration in government and commercial markets.

  • Achieved an 'A' ESG rating from Digbee, a significant improvement, and is progressing toward commercial production at the first mine to restart within an active EPA Superfund site. This unique ESG angle could attract impact investors.

  • Priced a $150M IPO targeting technology and software infrastructure for financial services, real estate, and asset management. The experienced management team (led by Shawn Matthews) and specific focus provide a clear investment thesis.

  • Terminated its deal with XYDD and is pursuing a new business combination with Data443 Risk Mitigation, Inc. The $2M promissory note to XYDD as compensation suggests a clean break and a potentially more attractive target.

  • Sold three hotel properties for $432.7M, repaying $232.8M in debt. While this reduces ongoing revenue, the pro forma net income improved from a loss of $72.7M to income of $96.7M, and the company now has a stronger balance sheet for future acquisitions.

  • Appointment of a Managing Director from KKR Credit Advisors as Chief Compliance Officer ensures strong regulatory oversight and alignment with KKR's best practices, reducing compliance risk.

  • Adopted a new severance plan and entered into new employment agreements with five top executives, including the CEO. This standardizes terms and provides retention incentives, signaling a stable leadership team.

Sector Themes (6)

  • Capital Raising Frenzy

    Multiple companies are aggressively accessing capital markets, with Csquare's $1.01B IPO, Penguin Solutions' $650M+ convertible note offering, and Uniti Group's $1.14B ABS securitization. This suggests a favorable environment for raising capital, but also indicates that companies are building war chests for growth or debt repayment.

  • Biotech Consolidation and Dilution

    The Jasper Therapeutics acquisition of Kira Pharmaceuticals is a prime example of a dilutive all-stock deal in the biotech sector. This trend of using stock as currency for M&A, combined with PIPE financing, is creating significant dilution for existing shareholders, even as it creates potentially valuable combined pipelines.

  • Financial Distress in Micro-Caps

    The Fuse Science receivership and Trans American Aquaculture restatement highlight the precarious state of many micro-cap companies. These events are characterized by a lack of internal controls, insolvency, and aggressive financing structures (e.g., CERo Therapeutics' convertible note), posing significant risks for investors.

  • Leadership Churn and Retention

    A wave of executive departures and appointments is sweeping across industries, from CFOs (Lindsay Corp, Energy Vault) to board members (Frontier, Everspin). Companies like Adobe and Karyopharm are implementing retention programs to lock in key talent, signaling a competitive market for experienced executives.

  • SPAC Market Resurgence

    The filing period shows renewed activity in the SPAC space, with Mercator Acquisition Corp. pricing a $150M IPO and Four Leaf Acquisition Corp. terminating one deal to pursue another. This suggests that the SPAC market is finding a new equilibrium, with a focus on specific sectors (e.g., technology, data security).

  • ESG and Governance as a Differentiator

    Bunker Hill Mining's 'A' ESG rating and the board refresh at International Paper (appointing a sustainable investing expert) highlight the growing importance of ESG and governance. Companies with strong ESG profiles are attracting attention, while those with governance failures (e.g., Trans American Aquaculture) face severe consequences.

Watch List (8)

Filing Analyses (50)
FLOTEK INDUSTRIES INC/CN/ 8-K neutral materiality 3/10

17-07-2026

FLOTEK INDUSTRIES INC/CN/ filed an 8-K on July 17, 2026, reporting Items 1.01 (Entry into a Material Definitive Agreement) and 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). The filing indicates the company entered into a material agreement that created a direct financial obligation, but no specific dollar values, transaction details, or counterparty names are disclosed. Without quantitative data, the materiality and financial impact cannot be assessed, and the filing appears to be a mandatory disclosure with no positive or negative performance metrics to report.

  • · Filing date: July 17, 2026
  • · AccNo: 0000928054-26-000069
  • · Size: 1 MB
  • · Items reported: 1.01 and 2.03 (multi-item filing)
  • · No specific dollar values, counterparty names, or transaction terms disclosed in the summary
  • · No scheduled events, guidance, or forward-looking statements mentioned
Bunker Hill Mining Corp. 8-K positive materiality 7/10

17-07-2026

Bunker Hill Mining Corp. announced the permanent appointment of Bradley Barnett as CFO and the appointment of Mark Hayes as General Counsel, effective August 10, 2026. The company also disclosed that it achieved an 'A' ESG rating from Digbee in its first Operations Phase assessment, a significant improvement from its prior rating. The mine restart is progressing toward commercial production, with expected direct employment of 200-250 people and indirect employment of ~1,000 jobs.

  • · The Bunker Hill Mine is located in Idaho's Silver Valley and has been closed for 45 years.
  • · The mine restart is the first commercial mining operation to restart within an active U.S. EPA Superfund site since the program began in 1969.
  • · Mark Hayes previously served as head of legal for Nuton, Rio Tinto's copper leaching technology venture.
  • · Mark Hayes earned a J.D. magna cum laude from the University of Oklahoma College of Law and a B.A. in Politics from Princeton University.
  • · Bradley Barnett was one of three founding members of the new management team that arrived in the Silver Valley in 2020.
Penguin Solutions, Inc. 8-K neutral materiality 8/10

17-07-2026

Penguin Solutions, Inc. announced a proposed private offering of $650.0 million in aggregate principal amount of convertible senior notes due 2031, with an option for initial purchasers to acquire an additional $100.0 million. Concurrently, the company expects to enter into privately negotiated exchanges of a portion of its existing 2.00% convertible senior notes due 2029 and 2030, and to use net proceeds to fund capped call transactions, repay $100.0 million outstanding under its credit agreement, and for general corporate purposes. The offering is subject to market conditions and the final terms have not been set.

  • · Notes will mature on August 1, 2031, unless earlier converted, redeemed or repurchased.
  • · Prior to May 1, 2031, conversion is only upon satisfaction of certain conditions; on or after May 1, 2031, holders may convert at any time.
  • · Penguin may redeem the notes on or after August 6, 2029, if stock price exceeds 130% of conversion price for a specified period.
  • · Capped call transactions are expected to reduce potential dilution upon conversion, but dilution may occur if market price exceeds the cap price.
  • · The offering is not registered under the Securities Act and is limited to qualified institutional buyers under Rule 144A.
Karyopharm Therapeutics Inc. 8-K neutral materiality 5/10

17-07-2026

Karyopharm Therapeutics implemented a 2026 Leadership Cash Retention Program on July 13, 2026, replacing the Annual Bonus Plan for named executive officers and the CFO to incentivize retention during a period of expected catalysts. The program provides lump sum cash awards totaling $3,715,000, with CEO Richard Paulson receiving $1,725,000, CFO Lori Macomber $625,000, and other executives receiving $640,000 and $725,000. Awards are subject to repayment if employment is terminated before 12 months (or 30 days post-corporate event) except for certain qualifying exits, and amounts paid reduce severance obligations.

  • · The program replaces previously guaranteed amounts under the Company’s Annual Bonus Plan for 2026.
  • · Awards are subject to repayment if employment is terminated for any reason other than by the Company without cause, by the participant for good reason, or due to death/permanent disability before 12 months from payment or 30 days following a qualifying corporate event.
  • · Amounts paid under the program reduce any amounts payable under previously agreed upon severance arrangements.
Four Leaf Acquisition Corp 8-K mixed materiality 8/10

17-07-2026

Four Leaf Acquisition Corp terminated its business combination agreement with Guangzhou Xiaoyu DiDa Technology Co., Ltd. (XYDD) on July 15, 2026, due to a halt in regulatory review under PRC law, in order to pursue a new business combination with Data443 Risk Mitigation, Inc. As compensation for the termination, Data443 issued a $2,000,000 promissory note to XYDD, payable in two installments after deal close, with potential conversion into PubCo shares at a discount. The company is not obligated to pay any termination fee.

  • · The XYDD Business Combination Agreement was originally entered into on December 19, 2024.
  • · The Compensation Agreement between Data443 and XYDD was entered into on June 25, 2026.
  • · Data443 may repay the loan in full at any time before 12 months after deal close.
  • · Any portion of the loan that cannot be converted due to the floor or cap remains payable in cash on demand.
  • · Disputes under the Compensation Agreement are to be resolved by arbitration administered by the Singapore International Arbitration Centre.
Uniti Group Inc. 8-K neutral materiality 7/10

17-07-2026

Uniti Group Inc. completed a $1.14B private offering of secured fiber network revenue term notes through its subsidiary Kinetic ABS Issuer LLC on July 15, 2026. The offering includes three tranches with interest rates ranging from 5.834% to 7.536% and an anticipated repayment date in June 2033. Proceeds will be used for general corporate purposes, including potential capital expenditures and debt repayment.

  • · The Series 2026-2 Term Notes have a legal final maturity in June 2058.
  • · Scheduled interest payments begin August 25, 2026, on the 25th of each month.
  • · No principal payments are due before the Term ARD (June 2033) unless rapid amortization or acceleration triggers are activated.
  • · A prefunding account of ~$91.08M was established for pending Oklahoma assets, subject to regulatory approvals by July 30, 2027.
  • · The notes are secured by fiber network assets and residential customer contracts in 10 states.
  • · The Issuer increased its liquidity funding note facility commitment and extended its maturity to align with the Series 2026-2 Term Notes.
  • · No new variable funding notes were issued in connection with this offering.
Jasper Therapeutics, Inc. 8-K mixed materiality 9/10

17-07-2026

Jasper Therapeutics, Inc. (NASDAQ: JSPR) announced the acquisition of Kira Pharmaceuticals in an all-stock transaction, concurrently raising $132 million in a PIPE offering. On a fully diluted basis, pre-transaction Jasper equityholders will own approximately 6.68%, Kira equityholders will own approximately 49.86%, and PIPE investors will own approximately 43.46% of the combined company. The combined entity plans to advance a pipeline including KP-104 (a bifunctional complement inhibitor targeting C5 and Factor H) and briquilimab (anti-KIT), with key milestones expected through 2028. However, the transaction significantly dilutes existing Jasper shareholders, and the company faces substantial risks related to clinical development, regulatory approval, and the realization of CVR payments contingent on a priority review voucher.

  • · The combined company expects to fund operations through 2H 2028 with the $132M PIPE proceeds.
  • · CVR payments of up to $30M are contingent on Jasper obtaining a priority review voucher for briquilimab by end of 2028.
  • · Out-license of KP-301 and KP-402 to Mirador Therapeutics includes $12M upfront and potential development/sales milestones.
  • · KP-104 has a Phase 2 basket trial with interim data expected Q4 2026 (Stage 1) and Q2 2027 (Stage 2).
  • · Briquilimab has Orphan Drug, Fast Track, and Rare Pediatric Disease Designations in SCID.
  • · The global complement inhibitor market is estimated at $14B+ (2025A-2032E).
Activate Energy Acquisition Corp. 8-K neutral materiality 2/10

17-07-2026

Activate Energy Acquisition Corp. (AEAQU) announced the resignation of Director Paul Moore from its Board, effective July 13, 2026. The departure was not related to any disagreement with the company regarding its operations, policies, or practices. The Board thanked Mr. Moore for his service.

  • · The resignation was effective immediately on July 13, 2026.
  • · The company is a blank check (SPAC) incorporated in the Cayman Islands.
  • · Its securities trade on the Nasdaq Global Market under symbols AEAQU (Units), AEAQ (Class A ordinary shares), and AEAQW (Warrants).
Targa Resources Corp. 8-K neutral materiality 4/10

17-07-2026

On July 16, 2026, Targa Resources Corp. appointed Thomas Mathiasmeier to its Board as a Class II Director (term expiring at the 2027 annual meeting) and named him to the Audit Committee. The company expects to grant a pro‑rated restricted stock award of 477 shares and entered into a standard indemnification agreement; no other compensation amounts or cash figures were disclosed. The filing discloses positive governance additions (experienced energy executive) but is otherwise routine with no related-party relationships or extraordinary payments disclosed.

  • · Appointment date: July 16, 2026 (report filed July 17, 2026).
  • · Mr. Mathiasmeier designated Class II Director with term expiring at the 2027 annual meeting of stockholders.
  • · Mr. Mathiasmeier was appointed as a member of the Board’s Audit Committee.
  • · Mr. Mathiasmeier most recently served as President, Global Gas, Power & Emerging Markets at ConocoPhillips and retired in June 2026.
  • · Company entered into an Indemnification Agreement requiring indemnification to the fullest extent permitted under Delaware law and advancement of expenses.
  • · Filing references prior SEC-filed exhibits for the form of the restricted stock agreement (Exhibit 10.13 to Form 10-K filed February 16, 2018) and the form of indemnification agreement (Exhibit 10.4 to Form S-1/A filed November 8, 2010).
BuzzFeed, Inc. 8-K neutral materiality 3/10

17-07-2026

BuzzFeed, Inc. appointed Stanley E. Washington as an independent director and Chair of the Compensation Committee, effective July 16, 2026, while Greg Coleman stepped down from the Board after serving since 2021. Washington brings over 40 years of experience in financial services, fintech, and payments, and will also serve on the Audit and Nominating Committees. The filing contains no financial results or period-over-period comparisons, and no negative or flat performance metrics are disclosed.

  • · Washington will serve on the Audit Committee, the Nominating, Corporate Governance, and Corporate Responsibility Committee, and as Chair of the Compensation Committee.
  • · Greg Coleman had been a Board member since the closing of the business combination in 2021 and served as Chair of the Compensation Committee.
  • · Washington currently serves as President and CEO of Pantheon Global Services Inc., an investment and advisory firm.
  • · Washington is a Trustee Emeritus of Morehouse College and holds a B.A. in Marketing from Morehouse College.
  • · No arrangements or understandings exist between Washington and any other person regarding his selection as a director, and no related party transactions are disclosed.
Braemar Hotels & Resorts Inc. 8-K mixed materiality 8/10

17-07-2026

Braemar Hotels & Resorts Inc. completed the sale of three hotel properties (The Ritz-Carlton Sarasota, Hotel Yountville, and Bardessono Hotel and Spa) for approximately $432.7 million in cash, net of transfer taxes and selling expenses, and repaid approximately $232.8 million on the related mortgage loan. The pro forma financials show a significant non-recurring gain of $158.2 million for the year ended December 31, 2025, but also reflect the removal of these properties' revenues and operating income, leading to a decline in ongoing hotel revenue from $704.0 million to $575.5 million. While the sale strengthens the balance sheet with increased cash and reduced debt, it also reduces the company's asset base and future operating income from the disposed properties.

  • · The sale closed on July 14, 2026.
  • · The pro forma gain on disposition is preliminary and subject to change.
  • · Pro forma net income attributable to common stockholders for the year ended Dec 31, 2025 improved from a loss of $72.7M to income of $96.7M, primarily due to the non-recurring gain.
  • · Pro forma net income attributable to common stockholders for the three months ended Mar 31, 2026 declined from $4.9M to $1.2M, reflecting the removal of the properties' operating results.
  • · Pro forma total assets decreased by $138.1M (7.5%) from $1.85B to $1.71B.
  • · Pro forma indebtedness decreased by $232.2M (21.0%) from $1.11B to $873.9M.
  • · Pro forma cash and cash equivalents increased by $188.2M (201.5%) from $93.4M to $281.6M.
  • · The disposed properties had combined operating losses (before gain) of $7.6M for the year ended Dec 31, 2025 and $1.9M for the three months ended Mar 31, 2026.
ESS Tech, Inc. 8-K neutral materiality 5/10

17-07-2026

ESS Tech, Inc. amended its at-the-market (ATM) offering program on July 16, 2026, terminating four of its five original sales agents (BMO, Canaccord, Needham, and Stifel) and adding Roth Capital Partners as the sole new agent. Roth also replaces Canaccord as the qualified independent underwriter for the offering. The ATM program remains authorized to sell up to $75 million of common stock, but the change in agents may signal a shift in the company's capital-raising strategy.

  • · The Original Sales Agreement was entered into on November 13, 2025.
  • · The amendment terminates BMO, Canaccord, Needham, and Stifel as sales agents.
  • · Roth Capital Partners replaces Canaccord as the qualified independent underwriter under FINRA Rule 5121.
  • · YA II PN, Ltd., an affiliate of Yorkville Ives, is a party to the company's Standby Equity Purchase Agreement and is the lender under a Promissory Note with ESS Tech.
  • · Yorkville Ives and Roth may provide future commercial banking, financial advisory, and investment banking services for customary fees.
Mercator Acquisition Corp. 8-K neutral materiality 8/10

17-07-2026

Mercator Acquisition Corp., a blank check company, priced its $150 million initial public offering of 15,000,000 units at $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. The units will trade on Nasdaq under the symbol 'MRCOU' starting July 9, 2026. The company intends to focus on technology and software infrastructure companies targeting financial services, real estate, and asset management, and is led by Shawn Matthews (Chairman & CEO), Steve Bischoff (CFO), and Shawn Matthews Jr. (President).

  • · The company is a blank check company formed to effect a merger or similar business combination.
  • · The offering was declared effective by the SEC on July 8, 2026.
  • · The company has granted underwriters a 45-day option to purchase up to an additional 2,250,000 units to cover over-allotments.
  • · Only whole warrants are exercisable and will trade separately.
IPG PHOTONICS CORP 8-K positive materiality 8/10

17-07-2026

IPG Photonics announced a binding offer to acquire Lumibird Medical for €300 million in cash (plus up to €50 million earnout), expanding its medical laser platform. The target reported €112.2 million revenue and €24.1 million EBITDA (21.5% margin) for FY2025, and the deal is expected to be accretive to gross margin, EBITDA, and adjusted EPS. The transaction is expected to close in Q4 2026, subject to works council consultation and customary conditions.

  • · Lumibird Medical is headquartered in France with three major global facilities.
  • · The company's brands include Quantel Medical, Ellex, and Optotek Medical.
  • · Lumibird Medical's historical financials are prepared under IFRS; a reconciliation to U.S. GAAP is included in the 8-K appendix.
  • · The acquisition will be funded with cash on hand.
  • · IPG expects the transaction to close during Q4 2026.
  • · A conference call is scheduled for July 17, 2026 at 8:00 a.m. ET.
LISATA THERAPEUTICS, INC. 8-K neutral materiality 3/10

17-07-2026

Lisata Therapeutics, Inc. has entered into an amendment to its Agreement and Plan of Merger with Kuva Labs Inc. and its acquisition subsidiary, extending the outside date for closing the merger from July 17, 2026 to July 21, 2026. The extension is a short, four-day delay, indicating the parties are still working to satisfy closing conditions but expect to complete the transaction imminently. No other terms of the merger agreement were modified.

  • · The original outside date was July 17, 2026; the amendment extends it to July 21, 2026.
  • · The amendment is dated July 16, 2026, one day before the original outside date.
  • · No other provisions of the Merger Agreement were changed.
GM Financial Consumer Automobile Receivables Trust 2026-3 8-K neutral materiality 5/10

17-07-2026

GM Financial Consumer Automobile Receivables Trust 2026-3 closed a $1.01579 billion asset-backed securitization on July 15, 2026, issuing multiple classes of notes and a certificate backed by prime auto loan receivables. The transaction includes $190M Class A-1 3.904% notes, $295.61M Class A-2-A 4.28% notes, $62M floating-rate Class A-2-B notes, $357.61M Class A-3 4.44% notes, $78.19M Class A-4 4.56% notes, $16.71M Class B 4.70% notes, and $15.67M Class C 4.89% notes, with the public notes sold to a syndicate led by Mizuho Securities. The securitization is a routine capital markets transaction for GM Financial, with no negative or flat performance metrics to report.

  • · The issuing entity was formed on June 3, 2026, and the trust agreement was amended and restated on July 15, 2026.
  • · GM Financial will serve as servicer and custodian of the receivables under the Sale and Servicing Agreement.
  • · Clayton Fixed Income Services LLC has been engaged as Asset Representations Reviewer to perform compliance reviews of certain receivables.
  • · The underwriting agreement was dated July 9, 2026, and the closing date was July 15, 2026.
  • · Legal opinions on validity and tax matters were provided by Katten Muchin Rosenman LLP.
Aditxt, Inc. 8-K neutral materiality 4/10

17-07-2026

Aditxt, Inc. entered into Amendment No. 2 to its Note Purchase Agreement on July 16, 2026, allowing a new investor (Doug Mergenthaler) to join, canceling a previously issued note, and issuing two additional senior secured notes with the same aggregate principal amount. The amendment did not change the total principal amount of notes outstanding, and the notes are secured by substantially all assets of subsidiary Ignite Proteomics LLC and a pledge of Ignite equity. No financial figures or period-over-period comparisons are provided in this filing.

  • · The amendment allows a new party (Doug Mergenthaler) to join as an Investor under the Purchase Agreement.
  • · A previously issued note (the Original Note) held by Cavalry Fund I SPV I LP was cancelled and replaced with two additional notes of equal aggregate principal amount.
  • · The additional notes are secured by substantially all assets of Ignite Proteomics LLC and a pledge of Ignite equity held by Aditxt.
  • · The offer and sale of the additional notes were exempt from registration under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.
Brand Engagement Network Inc. 8-K neutral materiality 4/10

17-07-2026

Brand Engagement Network Inc. appointed Christian Unterseer to its Board effective July 1, 2026, in connection with the previously announced acquisition of Cataneo GmbH. Mr. Unterseer, founder of Cataneo, will receive equity compensation per the Company's Board compensation policy. The filing does not disclose any financial terms of the acquisition or director compensation amounts.

  • · Mr. Unterseer founded Cataneo in September 2002 and grew it into a globally recognized enterprise platform serving leading media organizations.
  • · Prior to Cataneo, Mr. Unterseer was CEO of Home Shopping Europe UK (2000–2002) and Director, Ad Traffic & Broadcast Scheduling at ProSiebenSat1 Media AG.
  • · Mr. Unterseer holds a degree in media marketing (1992) from Bavarian Academy of Advertising, Munich.
  • · No family relationships or reportable transactions under Item 404(a) exist with Mr. Unterseer.
Tofla Megaline Inc. 8-K neutral materiality 3/10

17-07-2026

On June 4, 2026, Alejandro Araujo resigned from the Board of Directors of Tofla Megaline Inc., effective immediately. He also resigned from all board committees. Mr. Araujo confirmed his resignation was not due to any disagreement with the company. The Board will evaluate candidates to fill the vacancy.

  • · Resignation was effective immediately upon delivery of the letter on June 4, 2026.
  • · Mr. Araujo resigned from all board committees on which he served.
  • · The resignation was not due to any disagreement with the company's operations, policies, or practices.
  • · The Board intends to evaluate candidates to fill the vacancy.
AB INTERNATIONAL GROUP CORP. 8-K neutral materiality 2/10

17-07-2026

AI Era Corp. (ABQQ) announced that on July 17, 2026, its Board of Directors appointed Chiyuan Deng (Fred Deng), the current President and sole director, as Interim Chief Executive Officer and Interim Chief Financial Officer, effective immediately. Mr. Deng will serve in these roles under his existing Employment Agreement dated March 1, 2026, with no new material plans or arrangements entered into. The filing does not disclose any financial figures or performance metrics.

  • · Mr. Deng was appointed by written consent of the sole director.
  • · No family relationships exist between Mr. Deng and any other director or executive officer.
  • · No arrangements or understandings with any other person led to his selection as an officer.
  • · No material plan, contract, or arrangement was entered into or materially amended in connection with the appointment.
DAKTRONICS INC /SD/ 8-K neutral materiality 4/10

17-07-2026

Daktronics announced its fiscal 2027 executive compensation program on July 14, 2026, covering four named executive officers (NEOs). The program includes annual cash incentive awards based 60% on operating income and 40% on revenue, with payouts ranging from 50% to 150% of target, subject to a ±20% individual performance modifier. Long-term incentives are split 65% time-based RSUs and 35% performance-based PSUs tied to cumulative operating income and revenue over fiscal 2027-2029, with PSUs cliff-vesting after three years. The CEO, Ramesh Jayaraman, receives a 100% of base salary annual bonus target and a 200% long-term incentive target, while other NEOs have lower targets (50-60% annual, 60% long-term). The program does not apply to the Acting CFO or the EVP.

  • · The 2027 Compensation Program does not apply to Acting CFO Howard I. Atkins or EVP Bradley T. Wiemann, whose compensation is governed by previously filed arrangements.
  • · Annual incentive payouts are determined by linear interpolation between threshold and target, and between target and maximum performance levels.
  • · No annual incentive is paid if performance falls below threshold for a given goal.
  • · PSUs cliff-vest three years after grant, contingent on continued employment and certification of performance goal achievement by the Compensation Committee.
  • · PSU performance goals are based on cumulative operating income (60% weight) and cumulative revenue (40% weight) over fiscal 2027-2029.
Fuse Science, Inc. 8-K negative materiality 10/10

17-07-2026

Fuse Science, Inc. has had a receiver appointed by the Clark County District Court in Nevada after failing to satisfy a $643,471 judgment obtained by creditors Mina Mar Group, Mina 12, and Worldways Inc. The company reported $0 in assets and $0 in cash as of December 31, 2026, is insolvent, and has relocated its headquarters and assets abroad. The receiver, Peter D. Downey, has full authority to take control of all assets, investigate insider transactions, and wind down the business, while the company and its officers are enjoined from transferring assets or issuing shares.

  • · The receiver is authorized to investigate all transfers of assets and shares, including insider transactions, and to cancel improperly issued shares.
  • · The company is permanently enjoined from transferring, encumbering, or disposing of any assets, and from issuing any shares of capital stock.
  • · All financial institutions and third parties holding assets of Fuse Science must turn them over to the receiver upon demand.
  • · The receiver may retain professionals (attorneys, accountants, consultants) without prior court approval for expenditures up to $10,000 per matter.
  • · The receiver is not required to post a bond at this time, and is not personally liable for acts taken in good faith except for willful misconduct or gross negligence.
KKR Enhanced US Direct Lending Fund-L Inc. 8-K neutral materiality 3/10

17-07-2026

KKR Enhanced US Direct Lending Fund-L Inc. appointed Annette O'Donnell-Butner as Chief Compliance Officer effective July 8, 2026, replacing Mike Nguyen, who resigned. The resignation was not due to any disagreement with the company. O'Donnell-Butner is a Managing Director at KKR Credit Advisors (US) LLC since 2009 and will not receive direct compensation from the fund.

  • · Annette O'Donnell-Butner, age 57, joined KKR Credit Advisors (US) LLC in 2009 and is a Managing Director and Chief Compliance Officer.
  • · She holds a B.A. from Pennsylvania State University and a J.D. from Oklahoma City University School of Law.
  • · There is no family relationship between O'Donnell-Butner and any director or executive officer, and no reportable related party transactions.
  • · O'Donnell-Butner's appointment was not pursuant to any agreement or understanding with the company or any other person.
DEEP FISSION, INC. 8-K positive materiality 5/10

17-07-2026

Deep Fission, Inc. held its 2026 annual meeting on July 17, 2026, where stockholders voted on three proposals. All proposals passed with strong support: two Class I directors (Leslie Goldman Tepper and Blake E. Janover) were elected, Grant Thornton LLP was ratified as the independent auditor for FY 2026, and the 2025 Equity Incentive Plan was amended to increase authorized shares by 5,000,000. No negative or flat metrics were present in the filing.

  • · The two directors elected are Class I, with terms expiring at the 2029 annual meeting.
  • · No broker non-votes were cast on the director election or the equity plan amendment.
  • · The auditor ratification had 5,072,029 abstentions, while the equity plan amendment had 4,679,963 abstentions.
  • · The 2025 Equity Plan amendment was filed as Exhibit 10.1 to the 8-K.
Polomar Health Services, Inc. 8-K neutral materiality 3/10

17-07-2026

Polomar Health Services, Inc. dismissed its independent auditor, GreenGrowth CPAs, and engaged Haskell & White LLP as its new independent registered public accounting firm, effective July 8, 2026. The change was approved by the Audit Committee and ratified by the Board, with no disagreements or reportable events between the company and GreenGrowth during the relevant periods. The filing does not contain any financial results or period-over-period comparisons.

  • · GreenGrowth's reports on fiscal years ended December 31, 2024 and 2025 contained no adverse opinion, disclaimer, or qualification.
  • · No disagreements or reportable events occurred between the company and GreenGrowth during the fiscal years ended December 31, 2024 and 2025, and the subsequent interim period through July 7, 2026.
  • · Haskell & White LLP was appointed to audit the fiscal year ending December 31, 2026 and to review interim financials starting with the quarter ended June 30, 2026.
  • · The company had not consulted Haskell & White on any accounting, auditing, or financial reporting matters prior to engagement.
Bain Capital Private Credit 8-K neutral materiality 5/10

17-07-2026

Bain Capital Private Credit entered into a Fourth Amendment to its Senior Secured Revolving Credit Agreement, increasing the accordion feature from $800 million to $1 billion. The amendment also designates two new SPE subsidiaries (SLP 2 MM CLO WH 1, LLC and BCC Middle Market CLO 2026-1, LLC) and updates the lender schedule. No financial results or period-over-period comparisons are provided in this filing.

  • · The amendment is dated July 14, 2026 and filed on July 17, 2026.
  • · The existing credit agreement was originally dated December 29, 2023, with prior amendments on November 13, 2024, December 18, 2024, and January 30, 2026.
  • · The borrower represents that no default is continuing and all representations and warranties are true and correct.
  • · The amendment includes a reaffirmation of obligations by subsidiary guarantors.
Frontier Group Holdings, Inc. 8-K neutral materiality 3/10

17-07-2026

Frontier Group Holdings (ULCC) announced that board member Nancy Lipson will resign effective July 15, 2026, to pursue another business opportunity. The departure is not due to any disagreement with the company regarding operations, policies, or practices.

  • · Resignation effective July 15, 2026
  • · No disagreement with company operations, policies, or practices cited
EyePoint Pharmaceuticals, Inc. 8-K negative materiality 8/10

17-07-2026

EyePoint Pharmaceuticals entered into a settlement agreement with the DOJ and OIG-HHS to resolve alleged False Claims Act violations related to sales and marketing of DEXYCU, paying $4,678,981.86 plus interest and $166,500 in attorneys' fees. The company also entered a five-year Corporate Integrity Agreement requiring enhanced compliance oversight, board review, and an independent review organization. While the settlement avoids litigation costs and does not constitute an admission of liability, it imposes significant ongoing compliance obligations and potential penalties for non-compliance.

  • · Settlement payment due no later than 14 days after July 17, 2026 (Effective Date).
  • · Attorneys' fees of $166,500 due no later than 60 days after Effective Date.
  • · Company intends to use cash on hand to pay settlement and fees.
  • · Corporate Integrity Agreement requires retention of a board compliance expert, independent review organization, and employee screening for federal healthcare program exclusions.
  • · Failure to comply with Corporate Integrity Agreement could result in monetary penalties or exclusion from federal healthcare programs.
  • · Settlement releases company from civil or administrative monetary liability for the Covered Conduct and dismisses the relator's civil action.
Csquare, Inc. 8-K positive materiality 9/10

17-07-2026

Csquare, Inc. completed its initial public offering on July 17, 2026, selling 50,000,000 shares at $21.00 per share for net proceeds of $1,010.0 million. The company also entered into a Registration Rights Agreement and a Stockholders Agreement with Brookfield, granting Brookfield significant board nomination rights and consent over major actions while it holds at least 20% of outstanding common stock. The IPO and related agreements position Csquare with substantial capital and a major institutional investor, but also impose governance restrictions and potential dilution from an underwriter option for an additional 7,500,000 shares.

  • · IPO closed on July 17, 2026, with net proceeds of $1,010.0 million.
  • · Underwriters have a 30-day option to purchase up to an additional 7,500,000 shares at the IPO price.
  • · Brookfield can require registration of shares for resale if aggregate proceeds are expected to be at least $50.0 million.
  • · Brookfield has the right to nominate directors proportional to its ownership, and a majority if it owns over 50%.
  • · Csquare cannot grant registration rights to others without Brookfield's consent while Brookfield holds at least 20% of outstanding common stock.
  • · The company amended and restated its certificate of incorporation and bylaws in connection with the IPO.
ARS Pharmaceuticals, Inc. 8-K neutral materiality 5/10

17-07-2026

On July 15, 2026, ARS Pharmaceuticals, Inc. announced the resignation of board member Richard Lowenthal and the departure of Chief Medical Officer Sarina Tanimoto, M.D., both under conditions triggering severance benefits. The company agreed to additional one-time prorated bonus payments of $217,350 to Lowenthal and $111,780 to Tanimoto, contingent on signed release of claims. These executive departures represent a significant leadership change but do not include any financial results or operational metrics.

  • · Richard Lowenthal's resignation from the Board was a condition of his right to receive severance compensation under his employment agreement and the Company's Change in Control and Severance Benefit Plan.
  • · Dr. Tanimoto's cessation of employment was under conditions constituting a termination without cause.
  • · The additional one-time payments and severance benefits are conditioned on the effectiveness of the release of claims from each departing executive.
Trans American Aquaculture, Inc 8-K negative materiality 9/10

17-07-2026

Trans American Aquaculture, Inc. filed an 8-K on July 17, 2026, announcing that its previously issued audited financial statements for the fiscal year ended December 31, 2024, should no longer be relied upon due to material errors in liability classifications, accrued interest, notes payable, accumulated depreciation, and the accounting for a deed in lieu of foreclosure. The company identified material weaknesses in internal control over financial reporting, including the absence of a functioning audit committee and insufficient corporate governance. Management plans to file a restated 10-K/A to correct the errors.

  • · The restatement corrects errors in accrued interest expense, related-party notes payable, current portion of notes payable, notes payable net of current portion, other accrued expenses, and accumulated depreciation as of December 31, 2024.
  • · The restatement also reflects the accounting for the December 2, 2024 deed in lieu of foreclosure by Kings Aqua Farm, LLC, including write-off of farm property, extinguishment of the associated note payable, and a broodstock inventory write-down.
  • · Material weaknesses include absence of a functioning audit committee, insufficient documentation of internal controls, and insufficient corporate governance to ensure proper accounting for contractual agreements.
  • · The company has begun remediation, including engaging a third-party consulting firm to assist with internal control documentation.
Gogo Inc. 8-K neutral materiality 3/10

17-07-2026

Gogo Inc. announced an internal reorganization of its Satcom Direct Government subsidiary, effective July 15, 2026, in which Hayden Olson transitioned from EVP, General Manager, SD Government to EVP, Corporate Development. The reorganization is intended to improve operating efficiency and support previously disclosed synergy targets, but Mr. Olson is no longer deemed an executive officer of the company.

  • · The reorganization was finalized as of July 15, 2026.
  • · Mr. Olson continues to report to CEO Christopher Moore.
  • · Mr. Olson will oversee strategic initiatives and develop military/government partnership opportunities and new revenue opportunities for existing assets.
  • · Mr. Olson is no longer determined to be an 'executive officer' or 'officer' under SEC rules.
Hims & Hers Health, Inc. 8-K neutral materiality 3/10

17-07-2026

Hims & Hers Health, Inc. announced the resignation of Irene Becklund as Chief Accounting Officer and Principal Accounting Officer, effective October 9, 2026. Ms. Becklund's departure is not due to any dispute with the company's accounting practices. She will continue to support the company under an advisory agreement through July 10, 2027.

  • · Ms. Becklund served as Chief Accounting Officer since April 2025 and Principal Accounting Officer since November 2021.
  • · The advisory agreement runs from October 10, 2026 to July 10, 2027.
NovaBay Pharmaceuticals, Inc. 8-K neutral materiality 3/10

17-07-2026

Stablecoin Development Corporation (formerly NovaBay Pharmaceuticals, Inc., ticker SDEV) appointed Henry Blynn as Chief Operating Officer effective July 15, 2026, and set CEO Michael Kazley's 2027 salary at $400,000. Blynn receives a $300,000 base salary, a 50% target bonus, and 1,400,000 time-based RSUs vesting over three years. The filing reflects routine executive compensation and organizational changes with no negative financial metrics reported.

  • · Henry Blynn, age 32, previously served as Head of Business Operations and Strategy since March 2026 and as a consultant from October 2025.
  • · Blynn's RSUs vest in three equal installments: February 16, 2027; January 16, 2028; and January 16, 2029.
  • · CEO Michael Kazley has served without salary since October 2025 and will continue to do so for the remainder of fiscal year 2026.
  • · Kazley's target annual bonus remains not less than 100% of base salary, unchanged from prior arrangement.
  • · The company's common stock trades under the symbol SDEV on NYSE American.
GENERATION INCOME PROPERTIES, INC. 8-K mixed materiality 8/10

17-07-2026

Generation Income Properties, Inc. (GIPR) announced an amendment to its Series B-1 and B-2 Preferred Units to eliminate holder-controlled cash redemption rights, replacing them with rights to exchange for common stock. The company believes this will enable permanent equity classification and help achieve compliance with Nasdaq's $2.5 million minimum stockholders' equity requirement by the August 4, 2026 deadline. While the move aims to preserve the Nasdaq listing, the company faces ongoing delisting risk if compliance is not demonstrated.

  • · The amendment replaces holder-controlled cash redemption rights with exchange rights for common stock.
  • · The company previously received a Nasdaq extension to August 4, 2026 to demonstrate compliance.
  • · The company's independent auditor was consulted on the permanent equity classification.
  • · The company's common stock trades on The Nasdaq Capital Market under ticker GIPR.
Cadrenal Therapeutics, Inc. 8-K neutral materiality 4/10

17-07-2026

Cadrenal Therapeutics, Inc. (CVKD) disclosed the resignation of Chief Medical Officer Dr. James J. Ferguson III, effective July 31, 2026, and entered into a confidential separation agreement providing COBRA premium payments for up to six months post-separation. The company is actively searching for a replacement. No financial terms beyond standard salary through the separation date and COBRA premiums were disclosed, and no period-over-period financial comparisons are available in this filing.

  • · Dr. Ferguson's resignation was voluntary and effective July 31, 2026.
  • · The separation agreement includes a general release of claims and a non-disparagement clause.
  • · COBRA premium payments are contingent on Dr. Ferguson not becoming eligible for other group health coverage.
  • · The company is conducting a search for a new Chief Medical Officer.
ADOBE INC. 8-K neutral materiality 5/10

17-07-2026

Adobe Inc. approved a retention letter for Louise Pentland, Chief Legal Officer and EVP, providing enhanced severance benefits including 12 months of base salary, 100% target bonus, COBRA premiums, and accelerated equity vesting if terminated without cause or for good reason. The protections are temporary and will sunset 12 months after the new CEO starts. This filing reflects Adobe's efforts to retain key leadership during a CEO transition.

  • · The retention letter was approved by the Executive Compensation Committee on July 14, 2026.
  • · Accelerated vesting of 50% of Retention RSUs applies if termination occurs before July 15, 2027.
  • · Accelerated vesting of other time-based equity awards applies if termination occurs before January 31, 2027.
  • · Severance benefits are conditioned on execution and non-revocation of a release of claims.
  • · The protections sunset 12 months after the new CEO commences employment.
Spire Global, Inc. 8-K positive materiality 6/10

17-07-2026

Spire Global, Inc. (NYSE: SPIR) announced the appointment of Eric (“Mell”) Mellinger as Chief Commercial Officer, effective August 3, 2026. Mr. Mellinger joins from Mantech International, where he led a team that grew a $4B+ annual pipeline and contributed to over $2.5B in contract awards with double-digit YoY revenue growth. The appointment is aimed at accelerating revenue expansion across government and commercial markets, though no specific financial targets or current performance metrics were disclosed.

  • · Mr. Mellinger will be based in Spire's Vienna, Virginia headquarters.
  • · He previously served as House Armed Services Committee's Defense Acquisition Reform Staff Lead and spent 30 years in the U.S. Marine Corps, retiring as a Colonel.
  • · He holds a B.S. in Human Factors Engineering from the U.S. Air Force Academy, a Master of Military Studies from Marine Corps University, and a Master of Science in National Security Strategy from the National Defense University.
INTERNATIONAL PAPER CO /NEW/ 8-K neutral materiality 4/10

17-07-2026

International Paper announced the appointment of Katherine Collins and Lori J. Ryerkerk to its Board of Directors, effective October 1, 2026. The company also disclosed that two long-serving directors, Dr. Kathryn Sullivan (since 2017) and Ahmet C. Dorduncu (since 2011), will retire from the board at the end of 2026. The appointments bring new expertise in sustainable investing and global industrial operations, while the retirements mark a significant board refresh.

  • · Katherine Collins holds a master's degree in theological studies from Harvard Divinity School and a bachelor's degree in economics and Japanese studies from Wellesley College.
  • · Lori J. Ryerkerk holds a Bachelor of Science in Chemical Engineering from Iowa State University.
  • · Katherine Collins is a CFA charterholder and author of 'The Nature of Investing'.
  • · Lori Ryerkerk currently serves on the boards of Norfolk Southern, Cencora, and Eaton.
  • · Dr. Kathryn Sullivan has served on the IP board since 2017; Ahmet Dorduncu has served since 2011.
LINDSAY CORP 8-K neutral materiality 5/10

17-07-2026

Lindsay Corporation announced that CFO Sam Hinrichsen will resign effective August 31, 2026, for personal reasons with no disagreements with the company. He will provide transition services through December 31, 2026, receiving $100,000 for transition services, $110,000 in lieu of equity awards, his 2026 annual bonus, COBRA premium coverage, and a waiver of repayment of his cash signing bonus. The company has begun a search for a new CFO with an executive recruiting firm.

  • · Transition period runs from August 31, 2026 through December 31, 2026.
  • · Mr. Hinrichsen will receive his annual bonus under the Company's Management Incentive Plan for the 2026 Plan Year.
  • · Company will pay Mr. Hinrichsen's COBRA premium for four months following the Effective Date.
  • · Company waives any rights to repayment of Hinrichsen's cash signing bonus.
  • · Departure is not related to operations, policies, practices, or accounting issues.
Terrestrial Energy Inc. /DE/ 8-K neutral materiality 3/10

17-07-2026

Terrestrial Energy Inc. disclosed in an 8-K filing that the employment of Steven Millsap, General Counsel, Secretary and Chief Compliance Officer, will end effective September 12, 2026. The departure is noted as a routine officer change with no stated reason or replacement details. No financial impact or performance metrics were provided in the filing.

  • · The filing is an 8-K under Item 5.02, dated July 17, 2026, with the event occurring on July 14, 2026.
  • · Steven Millsap's employment ends September 12, 2026.
  • · No reason for departure or successor appointment is disclosed.
  • · Terrestrial Energy Inc. is an emerging growth company and has not elected the extended transition period for complying with new financial accounting standards.
Hilton Grand Vacations Inc. 8-K neutral materiality 3/10

17-07-2026

Hilton Grand Vacations Inc. entered into Amendment No. 10 to its Credit Agreement, establishing $850M in new Term Loans (Amendment No. 10 Term Loans) to fully repay its existing Initial Term Loans. The refinancing was facilitated by existing lenders converting on a cashless basis and one new lender joining, with no new cash borrowed overall—just a like-for-like replacement of one debt tranche with another.

  • · Amendment No. 10 is the tenth amendment to the credit agreement dated August 2, 2021.
  • · The new Term Loans repay all existing Initial Term Loans, with lenders that do not consent or elect to participate receiving cash repayment.
  • · One new lender (New Lender) is participating by acquiring its portion via assignment.
  • · Conditions for effectiveness include legal opinions, officer certificates, solvency certificate, and KYC/AML documentation.
  • · All accrued interest on Initial Term Loans was paid through the effective date.
  • · Administrative Agent received an amended engagement letter dated July 9, 2026, and related fee letters.
EVERSPIN TECHNOLOGIES INC. 8-K neutral materiality 2/10

17-07-2026

Everspin Technologies announced the resignation of board member Lawrence G. Finch, effective August 4, 2026. Mr. Finch also stepped down from the audit committee. The resignation was not due to any disagreement with the company. This is a routine board change with no financial impact.

  • · Resignation effective August 4, 2026.
  • · Mr. Finch also resigned from the audit committee.
  • · Resignation was not due to any disagreement with the company.
Hagerty, Inc. 8-K neutral materiality 5/10

17-07-2026

Hagerty, Inc. adopted a new Executive Severance and Change in Control Plan and entered into new or amended employment agreements with five top executives, effective July 15, 2026. CEO McKeel Hagerty receives a $1.2M base salary and enhanced severance (24 months), while new executive Russell Page joins with a $650,000 base salary and 100% target bonus. The plan standardizes severance terms across the leadership team, providing up to 24 months of salary continuation for the CEO and 18 months for other eligible executives upon qualifying terminations.

  • · The Severance Plan provides 24 months of salary continuation for McKeel Hagerty and 18 months for other eligible executives upon a Regular Termination.
  • · Upon a Change in Control Termination, McKeel Hagerty receives a lump-sum payment equal to 24 months of base salary plus 200% of target bonus; other executives receive 18 months of base salary plus 150% of target bonus.
  • · Performance-based equity awards vest upon a Change in Control Termination based on the greater of target and actual performance.
  • · Severance benefits are forfeited if an executive engages in a 'Prohibited Action' such as breach of confidentiality, non-competition, or non-solicitation covenants.
  • · Russell Page's employment agreement is new; the others are amended and restated versions of prior agreements.
CERO THERAPEUTICS HOLDINGS, INC. 8-K neutral materiality 7/10

17-07-2026

On July 14, 2026, CERo Therapeutics entered into a second amended and restated convertible promissory note with SRX Global Inc., increasing the maximum borrowing capacity to $2,085,200. The note carries a 10% annual interest rate, matures on May 28, 2027, and is convertible into common stock at a conversion price equal to the lesser of $0.05 or 80% of the average of the five lowest intraday trading prices over the prior 20 days. The company has also agreed to file a resale registration statement with the SEC for the shares issuable upon conversion.

  • · The note includes a 25% original issue discount (OID), meaning the maximum principal amount is $2,606,500 but the funded amount is capped at $2,085,200.
  • · Conversion price is the lesser of $0.05 (floor price) or 80% of the average of the five lowest intraday trading prices during the 20 days prior to conversion request.
  • · If the conversion price falls below the floor price, the company must make a cash payment to the lender equal to the difference.
  • · The lender is an accredited investor and the securities were issued under Section 4(a)(2) and Rule 506(b) exemptions.
  • · The company must file a resale registration statement (Form S-1 or S-3) with the SEC covering the shares issuable upon conversion.
Energy Vault Holdings, Inc. 8-K positive materiality 7/10

17-07-2026

Energy Vault Holdings, Inc. announced the appointment of Nitin Dahiya, a senior capital markets veteran from BlackRock's Direct Private Opportunities group, as its new Chief Financial Officer, effective July 27, 2026. Current CFO Michael Beer will transition out of the role. The appointment comes as the company reports accelerating growth, including multi-GWh IPP project wins in Australia, an 850MW IPP portfolio acquisition in Japan, AI compute infrastructure wins in the US, and a material increase in Q2 2026 contract backlog. However, the filing does not provide specific financial figures for the backlog increase, and the departure of the current CFO introduces transition risk.

  • · Nitin Dahiya will formally begin as CFO on July 27, 2026.
  • · Michael Beer, current CFO, is transitioning out to pursue other opportunities.
  • · Dahiya has over two decades of experience at firms including BlackRock, Paulson & Co., and Nomura.
  • · Energy Vault has deployed billions in investment capital across public and private markets.
  • · The company's Q2 2026 Earnings Call is scheduled for August 11, 2026, where the backlog increase and financial outlook will be discussed.
  • · Cory Magnuson was recently appointed President of the Asset Vault platform.
CLOUDASTRUCTURE, INC. 8-K mixed materiality 6/10

17-07-2026

Cloudastructure, Inc. (CSAI) held its annual meeting on July 15, 2026, where stockholders approved a one-time repricing of outstanding stock options under the 2024 Equity Incentive Plan and a reverse stock split (ratio 1-for-2 to 1-for-200). However, a proposal to decrease authorized shares from 500M to ~83.3M was not approved, and the election of director Jeff Kirby received significant broker non-votes (5.47M) and abstentions (952,654).

  • · The authorized share decrease proposal was defeated primarily by Series 2 Preferred stockholders (1,312,580 votes against).
  • · The option repricing amendment passed with 3,807,535 FOR vs 2,148,149 AGAINST, indicating significant shareholder opposition.
  • · Director Jeff Kirby received 952,654 abstentions and 5,471,865 broker non-votes, suggesting notable lack of support.
  • · The reverse stock split was approved by all voting classes, including Series 2 Preferred (1,312,580 FOR).
  • · TAAD LLP was ratified as auditor with 11,283,846 FOR votes.
Inflection Point Acquisition Corp. V 8-K neutral materiality 6/10

17-07-2026

Inflection Point Acquisition Corp. V (SPAC) and GOWell Technology Limited amended their business combination agreement on July 13, 2026, modifying the earnout share issuance thresholds for 2026 EBITDA performance and capping SPAC transaction expenses at $9 million. The amendment also adds a new schedule for advisory fees, with cash advisory fees to Cohen & Company Capital Markets capped at $2 million. The deal structure remains otherwise unchanged.

  • · The amendment is the second amendment to the original Business Combination Agreement dated October 13, 2025 (first amendment on December 22, 2025).
  • · The earnout share issuance is a one-time event per tier, not cumulative.
  • · Deferred underwriting commissions and non-cash advisory fees of Cohen & Company Capital Markets are excluded from the $9M SPAC expense cap.
  • · The amendment adds a new Schedule 11.3 to the agreement detailing advisory services.
Childrens Place, Inc. 8-K neutral materiality 4/10

17-07-2026

On July 13, 2026, Douglas Edwards resigned from the Board of The Children's Place, Inc., effective immediately, with no disagreement with the company. His departure reduced the Audit Committee to two members, causing a temporary non-compliance with Nasdaq's three-member requirement; the company expects to cure this by its next annual meeting in May 2027. The Board reconstituted committee leadership, appointing Hussan Arshad as Audit Committee Chair and Turki Saleh A. AlRajhi as Chair of the Corporate Responsibility, Sustainability & Governance Committee.

  • · Resignation was not due to any disagreement with the company on operations, policies, or practices.
  • · The company has until the earlier of its next annual meeting (expected May 2027) or one year from July 13, 2026 to add a third Audit Committee member to comply with Nasdaq Listing Rule 5605(c)(2)(A).
  • · The filing includes forward-looking statements regarding risks such as tariff impacts, supply chain disruptions, and litigation.
Ispire Technology Inc. 8-K neutral materiality 4/10

17-07-2026

Ispire Technology Inc. announced a leadership change on July 16, 2026, where Michael Wang was transitioned from Co-CEO to CEO of the subsidiary Aspire North America. As a result, Tuanfang Liu is now the sole CEO of the company. The filing contains no financial data or performance metrics.

  • · The change was effective July 16, 2026.
  • · Michael Wang's new role is CEO of Aspire North America, a wholly owned subsidiary.
  • · Tuanfang Liu is now the sole Chief Executive Officer of Ispire Technology Inc.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Material Events SEC 8-K Filings

🇺🇸 More from United States

View all →